Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.

The global market for Gastric Motility Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastric Motility Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gastric Motility Drugs by region & country, by Type, and by Application.

The Gastric Motility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Drugs.

Market Segmentation

Scope of Gastric Motility Drugs - Market Report

Report Metric	Details
Report Name	Gastric Motility Drugs - Market
CAGR	5%
Segment by Type:	Monotherapy Poly Pill
Segment by Application	Chronic Gastritis Reflux Esophagitis Functional Dyspepsia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gastric Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Gastric Motility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Gastric Motility Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Gastric Motility Drugs - Market report?

Ans: The main players in the Gastric Motility Drugs - Market are Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd

What are the Application segmentation covered in the Gastric Motility Drugs - Market report?

Ans: The Applications covered in the Gastric Motility Drugs - Market report are Chronic Gastritis, Reflux Esophagitis, Functional Dyspepsia, Others

What are the Type segmentation covered in the Gastric Motility Drugs - Market report?

Ans: The Types covered in the Gastric Motility Drugs - Market report are Monotherapy, Poly Pill

1 Market Overview

1.1 Gastric Motility Drugs Product Introduction

1.2 Global Gastric Motility Drugs Market Size Forecast

1.2.1 Global Gastric Motility Drugs Sales Value (2019-2030)

1.2.2 Global Gastric Motility Drugs Sales Volume (2019-2030)

1.2.3 Global Gastric Motility Drugs Sales Price (2019-2030)

1.3 Gastric Motility Drugs Market Trends & Drivers

1.3.1 Gastric Motility Drugs Industry Trends

1.3.2 Gastric Motility Drugs Market Drivers & Opportunity

1.3.3 Gastric Motility Drugs Market Challenges

1.3.4 Gastric Motility Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Gastric Motility Drugs Players Revenue Ranking (2023)

2.2 Global Gastric Motility Drugs Revenue by Company (2019-2024)

2.3 Global Gastric Motility Drugs Players Sales Volume Ranking (2023)

2.4 Global Gastric Motility Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Gastric Motility Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Gastric Motility Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Gastric Motility Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Gastric Motility Drugs

2.9 Gastric Motility Drugs Market Competitive Analysis

2.9.1 Gastric Motility Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Gastric Motility Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Motility Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Monotherapy

3.1.2 Poly Pill

3.2 Global Gastric Motility Drugs Sales Value by Type

3.2.1 Global Gastric Motility Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Gastric Motility Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Gastric Motility Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Gastric Motility Drugs Sales Volume by Type

3.3.1 Global Gastric Motility Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Gastric Motility Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Gastric Motility Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Gastric Motility Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Chronic Gastritis

4.1.2 Reflux Esophagitis

4.1.3 Functional Dyspepsia

4.1.4 Others

4.2 Global Gastric Motility Drugs Sales Value by Application

4.2.1 Global Gastric Motility Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Gastric Motility Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Gastric Motility Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Gastric Motility Drugs Sales Volume by Application

4.3.1 Global Gastric Motility Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Gastric Motility Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Gastric Motility Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Gastric Motility Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Gastric Motility Drugs Sales Value by Region

5.1.1 Global Gastric Motility Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Gastric Motility Drugs Sales Value by Region (2019-2024)

5.1.3 Global Gastric Motility Drugs Sales Value by Region (2025-2030)

5.1.4 Global Gastric Motility Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Gastric Motility Drugs Sales Volume by Region

5.2.1 Global Gastric Motility Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Gastric Motility Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Gastric Motility Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Gastric Motility Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Gastric Motility Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Gastric Motility Drugs Sales Value, 2019-2030

5.4.2 North America Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Gastric Motility Drugs Sales Value, 2019-2030

5.5.2 Europe Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Gastric Motility Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Gastric Motility Drugs Sales Value, 2019-2030

5.7.2 South America Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Gastric Motility Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Gastric Motility Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Gastric Motility Drugs Sales Value

6.2.1 Key Countries/Regions Gastric Motility Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Gastric Motility Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Gastric Motility Drugs Sales Value, 2019-2030

6.3.2 United States Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Gastric Motility Drugs Sales Value, 2019-2030

6.4.2 Europe Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Gastric Motility Drugs Sales Value, 2019-2030

6.5.2 China Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Gastric Motility Drugs Sales Value, 2019-2030

6.6.2 Japan Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Gastric Motility Drugs Sales Value, 2019-2030

6.7.2 South Korea Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Gastric Motility Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Gastric Motility Drugs Sales Value, 2019-2030

6.9.2 India Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Gastric Motility Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Gastric Motility Drugs Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Sumitomo Dainippon

7.2.1 Sumitomo Dainippon Company Information

7.2.2 Sumitomo Dainippon Introduction and Business Overview

7.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sumitomo Dainippon Gastric Motility Drugs Product Offerings

7.2.5 Sumitomo Dainippon Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Gastric Motility Drugs Product Offerings

7.3.5 Sanofi Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Gastric Motility Drugs Product Offerings

7.4.5 Pfizer Recent Development

7.5 Teva

7.5.1 Teva Company Information

7.5.2 Teva Introduction and Business Overview

7.5.3 Teva Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Teva Gastric Motility Drugs Product Offerings

7.5.5 Teva Recent Development

7.6 GrupoFarma

7.6.1 GrupoFarma Company Information

7.6.2 GrupoFarma Introduction and Business Overview

7.6.3 GrupoFarma Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 GrupoFarma Gastric Motility Drugs Product Offerings

7.6.5 GrupoFarma Recent Development

7.7 Abbott

7.7.1 Abbott Company Information

7.7.2 Abbott Introduction and Business Overview

7.7.3 Abbott Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Abbott Gastric Motility Drugs Product Offerings

7.7.5 Abbott Recent Development

7.8 Kyowa Kirin

7.8.1 Kyowa Kirin Company Information

7.8.2 Kyowa Kirin Introduction and Business Overview

7.8.3 Kyowa Kirin Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Kyowa Kirin Gastric Motility Drugs Product Offerings

7.8.5 Kyowa Kirin Recent Development

7.9 Sigma-Tau Group

7.9.1 Sigma-Tau Group Company Information

7.9.2 Sigma-Tau Group Introduction and Business Overview

7.9.3 Sigma-Tau Group Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Sigma-Tau Group Gastric Motility Drugs Product Offerings

7.9.5 Sigma-Tau Group Recent Development

7.10 Wilmington

7.10.1 Wilmington Company Information

7.10.2 Wilmington Introduction and Business Overview

7.10.3 Wilmington Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Wilmington Gastric Motility Drugs Product Offerings

7.10.5 Wilmington Recent Development

7.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd

7.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information

7.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Introduction and Business Overview

7.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product Offerings

7.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Development

7.12 Lunan Pharmaceutical Group Corporation

7.12.1 Lunan Pharmaceutical Group Corporation Company Information

7.12.2 Lunan Pharmaceutical Group Corporation Introduction and Business Overview

7.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product Offerings

7.12.5 Lunan Pharmaceutical Group Corporation Recent Development

7.13 Hansoh Pharmaceutical Group Company Limited

7.13.1 Hansoh Pharmaceutical Group Company Limited Company Information

7.13.2 Hansoh Pharmaceutical Group Company Limited Introduction and Business Overview

7.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product Offerings

7.13.5 Hansoh Pharmaceutical Group Company Limited Recent Development

7.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd

7.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information

7.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Introduction and Business Overview

7.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product Offerings

7.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Development

7.15 Disha Pharmaceutical Group Co., Ltd

7.15.1 Disha Pharmaceutical Group Co., Ltd Company Information

7.15.2 Disha Pharmaceutical Group Co., Ltd Introduction and Business Overview

7.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product Offerings

7.15.5 Disha Pharmaceutical Group Co., Ltd Recent Development

7.16 Xian Janssen Pharmaceutical Ltd

7.16.1 Xian Janssen Pharmaceutical Ltd Company Information

7.16.2 Xian Janssen Pharmaceutical Ltd Introduction and Business Overview

7.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product Offerings

7.16.5 Xian Janssen Pharmaceutical Ltd Recent Development

8 Industry Chain Analysis

8.1 Gastric Motility Drugs Industrial Chain

8.2 Gastric Motility Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Gastric Motility Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Gastric Motility Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Lunan Pharmaceutical Group Corporation

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Xian Janssen Pharmaceutical Ltd.

GrupoFarma

Chengdu Kanghong Pharmaceutical Group Co.,Ltd

Hansoh Pharmaceutical Group Company Limited

Disha Pharmaceutical Group Co., Ltd

List of Tables

Table 1. Gastric Motility Drugs Market Trends

Table 2. Gastric Motility Drugs Market Drivers & Opportunity

Table 3. Gastric Motility Drugs Market Challenges

Table 4. Gastric Motility Drugs Market Restraints

Table 5. Global Gastric Motility Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Gastric Motility Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Gastric Motility Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Gastric Motility Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Gastric Motility Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Gastric Motility Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Gastric Motility Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Gastric Motility Drugs

Table 13. Global Gastric Motility Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Motility Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastric Motility Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Gastric Motility Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Gastric Motility Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Gastric Motility Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Gastric Motility Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Gastric Motility Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Gastric Motility Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Gastric Motility Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Gastric Motility Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Gastric Motility Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Gastric Motility Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Gastric Motility Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Gastric Motility Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Gastric Motility Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Gastric Motility Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Gastric Motility Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Gastric Motility Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Gastric Motility Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Gastric Motility Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Gastric Motility Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Gastric Motility Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Gastric Motility Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Gastric Motility Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Gastric Motility Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Gastric Motility Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Gastric Motility Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Gastric Motility Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Gastric Motility Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Gastric Motility Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Gastric Motility Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Gastric Motility Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Gastric Motility Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Gastric Motility Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Gastric Motility Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Gastric Motility Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Gastric Motility Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Gastric Motility Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Gastric Motility Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Gastric Motility Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Gastric Motility Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Gastric Motility Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Gastric Motility Drugs Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Sumitomo Dainippon Company Information

Table 63. Sumitomo Dainippon Introduction and Business Overview

Table 64. Sumitomo Dainippon Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Sumitomo Dainippon Gastric Motility Drugs Product Offerings

Table 66. Sumitomo Dainippon Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Gastric Motility Drugs Product Offerings

Table 71. Sanofi Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Pfizer Gastric Motility Drugs Product Offerings

Table 76. Pfizer Recent Development

Table 77. Teva Company Information

Table 78. Teva Introduction and Business Overview

Table 79. Teva Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Teva Gastric Motility Drugs Product Offerings

Table 81. Teva Recent Development

Table 82. GrupoFarma Company Information

Table 83. GrupoFarma Introduction and Business Overview

Table 84. GrupoFarma Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. GrupoFarma Gastric Motility Drugs Product Offerings

Table 86. GrupoFarma Recent Development

Table 87. Abbott Company Information

Table 88. Abbott Introduction and Business Overview

Table 89. Abbott Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Abbott Gastric Motility Drugs Product Offerings

Table 91. Abbott Recent Development

Table 92. Kyowa Kirin Company Information

Table 93. Kyowa Kirin Introduction and Business Overview

Table 94. Kyowa Kirin Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Kyowa Kirin Gastric Motility Drugs Product Offerings

Table 96. Kyowa Kirin Recent Development

Table 97. Sigma-Tau Group Company Information

Table 98. Sigma-Tau Group Introduction and Business Overview

Table 99. Sigma-Tau Group Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Sigma-Tau Group Gastric Motility Drugs Product Offerings

Table 101. Sigma-Tau Group Recent Development

Table 102. Wilmington Company Information

Table 103. Wilmington Introduction and Business Overview

Table 104. Wilmington Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Wilmington Gastric Motility Drugs Product Offerings

Table 106. Wilmington Recent Development

Table 107. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information

Table 108. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Introduction and Business Overview

Table 109. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product Offerings

Table 111. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Development

Table 112. Lunan Pharmaceutical Group Corporation Company Information

Table 113. Lunan Pharmaceutical Group Corporation Introduction and Business Overview

Table 114. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product Offerings

Table 116. Lunan Pharmaceutical Group Corporation Recent Development

Table 117. Hansoh Pharmaceutical Group Company Limited Company Information

Table 118. Hansoh Pharmaceutical Group Company Limited Introduction and Business Overview

Table 119. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product Offerings

Table 121. Hansoh Pharmaceutical Group Company Limited Recent Development

Table 122. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information

Table 123. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Introduction and Business Overview

Table 124. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product Offerings

Table 126. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Development

Table 127. Disha Pharmaceutical Group Co., Ltd Company Information

Table 128. Disha Pharmaceutical Group Co., Ltd Introduction and Business Overview

Table 129. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product Offerings

Table 131. Disha Pharmaceutical Group Co., Ltd Recent Development

Table 132. Xian Janssen Pharmaceutical Ltd Company Information

Table 133. Xian Janssen Pharmaceutical Ltd Introduction and Business Overview

Table 134. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product Offerings

Table 136. Xian Janssen Pharmaceutical Ltd Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Gastric Motility Drugs Downstream Customers

Table 140. Gastric Motility Drugs Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastric Motility Drugs Product Picture

Figure 2. Global Gastric Motility Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Gastric Motility Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Gastric Motility Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Gastric Motility Drugs Report Years Considered

Figure 7. Global Gastric Motility Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Gastric Motility Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastric Motility Drugs Revenue in 2023

Figure 10. Gastric Motility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Monotherapy Picture

Figure 12. Poly Pill Picture

Figure 13. Global Gastric Motility Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Gastric Motility Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Gastric Motility Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Gastric Motility Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Gastric Motility Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Chronic Gastritis

Figure 19. Product Picture of Reflux Esophagitis

Figure 20. Product Picture of Functional Dyspepsia

Figure 21. Product Picture of Others

Figure 22. Global Gastric Motility Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Gastric Motility Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Gastric Motility Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Gastric Motility Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Gastric Motility Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Gastric Motility Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Gastric Motility Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Gastric Motility Drugs Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Gastric Motility Drugs Sales Volume (%), (2019-2030)

Figure 39. United States Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 45. China Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. China Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 57. India Gastric Motility Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Gastric Motility Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. India Gastric Motility Drugs Sales Value by Application (%), 2023 VS 2030

Figure 60. Gastric Motility Drugs Industrial Chain

Figure 61. Gastric Motility Drugs Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Clotting Factors Ⅷ Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-21S8513

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Rare Genetic Disease Diagnosis Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17L15214

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Endoscopes for Otology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19V14797

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions